Tag: OYster Point Pharma

September 19, 2019 Off

Oyster Point Pharma Expands Executive Leadership Team

Appoints Dan Lochner as Chief Financial Officer Appoints John Snisarenko as Chief Commercial Officer PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc.,…

April 25, 2019 Off

Oyster Point Pharma to Present at the 2019 ASCRS•ASOA Annual Meeting and at the Ophthalmology Innovation Summit (OIS) Meeting

By BusinessWire

PRINCETON, N.J.–(BUSINESS WIRE)–Oyster Point Pharma, Inc., a privately held clinical-stage pharmaceutical company with an initial focus on developing novel therapies…